Aquestive Therapeutics, Inc. — Director's Dealing 2021

Jan 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2020-12-30

Reporting Person: Kendall Keith J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-30	Common Stock	G	1000	—	Disposed	638149	Direct
2020-12-30	Common Stock	G	1000	—	Acquired	1000	Indirect
2020-12-30	Common Stock	G	1000	—	Disposed	637149	Direct
2020-12-30	Common Stock	G	1000	—	Acquired	1000	Indirect

Footnotes

F1: On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Colin Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account. The reporting person disclaims beneficial ownership of the shares held by his grandchild.

F2: Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

F3: On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild William Kendall Conner, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account. The reporting person disclaims beneficial ownership of the shares held by his grandchild.